Whistle-blower complains to SEBI against Sun Pharma, alleges insider trading: Report

150-page document sent to market regulator in September, drugmaker says it has not yet been contacted by SEBI.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ShJyuu
via IFTTT